πŸ‡ΊπŸ‡Έ FDA
Patent

US 8481044

Neprilysin inhibitors

granted A61KA61K31/351A61K31/415

Quick answer

US patent 8481044 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/351, A61K31/415, A61K31/4155, A61K31/4164